Abstract
Introduction
Cancer is a major health problem and a devastating disease. People living with cancer experience a variety of signs and symptoms. Cancer patients undergo physical, psychological, social, and financial implications due to the disease and its treatment. Cancer harshly affects the individual’s health and deteriorates the quality of life (QoL). This study assesses the QoL determinants among various cancer patient groups in western Maharashtra, India.
Materials and methods
This hospital-based cross-sectional study was conducted in the oncology center, Krishna Vishwa Vidyapeeth, Karad, India. The study consisted of 270 cancer patients selected by purposive sampling technique. The data regarding the QoL was collected using a structured and validated questionnaire consisting of 50 questions elicited through one-to-one interviews. Data were analyzed using statistical software.
Results
Of 270 cancer patients, 135 (50%) were males and 135 (50%) were females aged between 22 and 66 years. Maximum patients (N = 89, 32.9%) were in the age group of 41-50 years, and the majority of patients (N = 34, 12.6%) suffered from breast cancer. The QoL among our patients was very low in 104 (38.5%) and 127 (47.0%), average in 36 (13.3%), and high only in 3 (1.1%) patients.
Conclusion
QoL among cancer patients was influenced by their symptoms, treatment, and the financial strain they experienced. There is a need to develop interventions to effectively manage symptoms that will help patients gain a greater sense of control over their illness and treatment, thereby improving their QoL.
Keywords: india, palliative care, western maharashtra, quality of life, general well-being, cancer patients
Introduction
Cancers are a group of diseases that cause abnormal cell growth, which invades other parts of the body and greatly affects every essence of quality living. Malignant cells can invade and destroy normal body tissue and spread to other parts of the body, which is known as metastasis. This invasion disrupts the affected tissues and organs and significantly impacts the overall quality of life (QoL) of individuals diagnosed with the disease. Cancer is also the leading cause of morbidity and mortality across the world.
The estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427. One in nine people in India is likely to develop cancer in his/her lifetime [1]. Cancer diagnosis and treatment introduce plenty of challenges, significantly impacting all the domains of QoL. Cancer causes various signs and symptoms, which range from subtle to noticeable. The type, size, and stage of the cancer and its potential impact on vital organs or systems influence QoL [2].
The QoL refers to how much a person can enjoy the valued possibilities of their lives [3]. QoL is a critical aspect of healthcare, particularly for cancer patients, as it encompasses physical, emotional, and social well-being. Health-related QoL (HRQOL) encompasses the impact of health status on QoL [4]. The HRQOL of an individual deteriorates when he/she is diagnosed with cancer, as well as when they are undergoing treatment, which ultimately affects their overall QoL. The assessment of HRQOL in cancer patients will shed light on their sufferings and help healthcare professionals offer holistic support and enhance patient care. With this background, the present study aimed to assess the determinants of QoL among various cancer patient groups in Western Maharashtra, India.
Materials and methods
Study design
This hospital-based cross-sectional study was conducted in the oncology center, involving 270 patients diagnosed with different types of cancers. The study employed the questionnaire adopted from the European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30) to assess relevant parameters [5]. The patient information sheet was provided, and informed consent was obtained from all the patients. The study included subjects who were undergoing various cancer treatments for different types of cancer and had provided their consent to participate. Patients who did not provide informed consent and patients with communication barriers were excluded from the study.
Sample size estimation
The sample size for this study was calculated based on the results of the pilot study and on the level of significance (alpha error) of 5% and power of 80% using the statistical formula: N = (Z1)2[P(1 - P)]/d2, (N = 270).
Ethical issues
Ethical clearance was obtained from the institutional ethical committee of Krishna Vishwa Vidyapeeth (reference no: 202/2022-2023 dated: 17.1.2023). The study was conducted according to the Modified Helsinki Declaration [6].
Pilot study
A pilot study was conducted among 30 cancer patients using a questionnaire consisting of 50 questions to check the authenticity of the results. The results of the pilot study determined the reliability and validity of the pre-tested questionnaire. Of 30 cancer patients, six patients with breast cancer showed poor QoL, followed by esophageal, colorectal, and oral cancers. The pilot study results demonstrated that the questions employed were both valid and reliable. Additionally, the analysis revealed variability in responses across different groups of cancer patients, indicating that the type of cancer greatly influences the QoL. That is why we considered the type of cancer as an element in our questionnaire.
Collection of questionnaire data
A one-to-one interview with cancer patients or family members was employed to collect the data regarding the HRQOL. The assessment tool used in this study was the Marathi version of the European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30) questionnaire [7].
Analysis of data
Statistical analysis was performed using IBM SPSS Statistics, version 22.0 (IBM Corp., Armonk, NY). Data analysis was performed using descriptive and inferential statistics. The obtained data were analyzed and compared statistically using an ANOVA test. The p-value of <0.05 was considered significant.
Results
The mean age of the 270 patients was 45.56 ± 8.78 (mean ± standard deviation) years. The majority of patients were in the age group of 41-50 years (N = 89, 32.96%), followed by the age group of 51-60 years (N = 84, 31.11%), 31-40 years (N = 81, 30%), 21-30 years (N = 10, 3.7%), and above 60 years (N = 6, 2.22%). We considered an equal number of male (N = 135, 50%) and female (N = 135, 50%) patients in our study to reduce the gender bias of our results. The educational status of the patients showed that the majority of individuals were graduates and post-graduates (N = 173, 64.07%), followed by intermediate and post-high school (N = 61, 22.5%), high school (N = 18, 6.67%), primary school (N = 12, 4.44%), and middle school (N = 60, 2.22%). Distribution of patients according to socioeconomic status showed that the majority of patients were from the upper middle class (N = 84, 31.11%), followed by lower middle (N = 65, 24.07%), upper class (N = 62, 22.96%), upper lower class (N = 51, 18.89%), and lower class (N = 8, 2.96%).
Distribution of patients according to type of cancer showed that the majority of patients were suffering from breast cancer (N = 34, 12.59%), followed by stomach cancer (N = 32, 11.85%) (Table 1).
Table 1. Distribution of patients according to type of cancer.
Cancer | Frequency | Percentage |
Bladder | 12 | 4.44 |
Brain | 05 | 1.85 |
Blood | 09 | 3.33 |
Breast | 34 | 12.59 |
Colon | 17 | 6.29 |
Colorectal | 20 | 7.40 |
Endometrial | 05 | 1.85 |
Kidney | 10 | 3.70 |
Liver | 24 | 8.89 |
Lung | 19 | 7.03 |
Esophagus | 07 | 2.59 |
Oral | 18 | 6.67 |
Pancreatic | 05 | 1.85 |
Prostate | 10 | 3.70 |
Rectum | 16 | 5.92 |
Stomach | 32 | 11.85 |
Thyroid | 05 | 1.85 |
Uterine | 22 | 8.15 |
Total | 270 | 100 |
The general well-being parameters of the patients were assessed, and we found that the majority of patients had moderate overall QoL (N = 228, 84.4%). All patients had moderate overall physical condition during the past month (Table 2).
Table 2. Distribution of patients according to general well-being parameters.
Parameters | Very much, N (%) | Moderate, N (%) | Little, N (%) | Not at all, N (%) |
How do you rate your overall quality of life during the past month? | 00 | 228 (84.4%) | 42 (15.6%) | 00 |
How would you rate your overall physical condition during the past month? | 00 | 270 (100%) | 00 | 00 |
Do you feel you are physically performing less than what you want to do? | 00 | 159 (58.9%) | 111 (41.1%) | 00 |
Do you feel confident about managing your financial needs in any situation? | 00 | 142 (52.6%) | 128 (47.4%) | 00 |
Do you experience any pain at present? | 00 | 111 (41.1%) | 159 (58.9%) | 00 |
Does your pain interfere with your day-to-day activity? | 00 | 142 (52.6%) | 128 (47.4%) | 00 |
Is your appetite normal? | 00 | 270 (100%) | 00 | 00 |
Do you have any problem sleeping peacefully? | 00 | 59 (21.6%) | 181 (67.1%) | 30 (11.1%) |
Do you feel you need more rest? | 00 | 87 (32.2%) | 183 (67.8%) | 00 |
Do you feel fatigued? | 170 (62.9%) | 100 (37.1%) | 00 | 00 |
Are you able to move around (physically) as usual? | 34 (12.6%) | 117 (43.3%) | 119 (44.1%) | 00 |
Do you have problems in passing urine? | 00 | 116 (42.9%) | 154 (57.1%) | 00 |
Do you have problems in passing motion? | 00 | 128 (47.4%) | 142 (52.6%) | 00 |
Are you satisfied with your working capacity? | 00 | 128 (47.4%) | 142 (52.6%) | 00 |
The psychological and cognitive well-being parameters among patients showed that the majority of patients felt moderate (N = 141, 52.2%) about themselves. Mostly (N = 155, 57.4%) patients had no difficulty remembering things. The majority of patients were dependent (N = 180, 66.7%) on medication (Table 3).
Table 3. Distribution of patients according to psychological and cognitive well-being parameters.
Parameters | Very much, N (%) | Moderate, N (%) | Little, N (%) | Not at all, N (%) |
How important do you feel about yourself at present? | 41 (15.2%) | 141 (52.2%) | 88 (32.6%) | 00 |
Have you had difficulty remembering things? | 00 | 00 | 115 (42.6%) | 155 (57.4%) |
How dependent are you on medication? | 180 (66.7%) | 90 (33.3%) | 00 | 00 |
The distribution of patients according to QoL showed that 47.04% (N = 127) had a low QoL, 38.52% (N = 104) had a very low QoL, and 13.33% (N = 36) had an average QoL (Table 4).
Table 4. Distribution of patients according to quality of life.
Quality of life (score) | Frequency (N) | Percentage (%) |
Very high (>82.5) | 00 | 00 |
High (73.5-82.5) | 03 | 01.11 |
Average (59-73) | 36 | 13.33 |
Low (49.5-58.5) | 127 | 47.04 |
Very low (<49.5) | 104 | 38.52 |
Total | 270 | 100 |
Table 5 shows the association between QoL and demographic variables. It was observed that age shows no statistically significant association with QoL among cancer patients (p > 0.05 by ANOVA test). Similarly, sex and socioeconomic status show no statistically significant association with QoL among cancer patients (p > 0.05 by ANOVA test).
Table 5. Association of quality of life and demographic variables.
Demographic variables | QOL score (mean ± SD) | p-value | |
Age group (years) | 21-30 | 106.12 ± 12.17 | 0.38 (NS) |
31-40 | 105.23 ± 11.21 | ||
41-50 | 104.19 ± 8.78 | ||
51-60 | 104.29 ± 10.14 | ||
>60 | 104.21 ± 10.10 | ||
Sex | Male | 105.29 ± 12.47 | 0.71 (NS) |
Female | 105.71 ± 12.10 | ||
Socioeconomic status | Upper class | 102.14 ± 13.92 | 0.19 (NS) |
Upper middle class | 103.13 ± 12.28 | ||
Lower middle class | 104.13 ± 12.51 | ||
Upper lower class | 104.33 ± 11.78 | ||
Lower class | 106.19 ± 11.31 | ||
(p-value >0.05: statistically not significant) |
Table 6 shows the association between QoL and type of cancer. We observed that type of cancer shows a statistically significant association with QoL among cancer patients (p < 0.05 by ANOVA test).
Table 6. Association of quality of life and type of cancer.
Cancer | QOL score (mean ± SD) | p-value |
Bladder | 105.18 ± 10.11 | 0.03 (significant) |
Brain | 104.12 ± 10.18 | |
Blood | 110.12 ± 10.23 | |
Breast | 103.11 ± 10.18 | |
Colon | 107.18 ± 12.24 | |
Colorectal | 108.12 ± 14.19 | |
Endometrial | 102.10 ± 10.21 | |
Kidney | 105.23 ± 11.16 | |
Liver | 107.18 ± 12.18 | |
Lung | 108.45 ± 13.44 | |
Esophagus | 107.29 ± 12.67 | |
Oral | 104.12 ± 12.18 | |
Pancreatic | 106.11 ± 12.12 | |
Prostate | 101.19 ± 12.23 | |
Rectum | 105.29 ± 10.13 | |
Stomach | 106.45 ± 10.82 | |
Thyroid | 105.21 ± 10.88 | |
Uterine | 102.24 ± 7.36 | |
(p-value <0.05: statistically significant) |
Discussion
Cancer is one of the major health issues and a devastating disease that affects all aspects of a healthy life. Various cancers impacting multiple organs are the leading causes of death worldwide. Cancer patients experience numerous symptoms throughout their illness, significantly affecting their QoL. In the present study on evaluating the QoL among different cancer types, it has been observed that both the specific type of cancer and the various treatment modalities exert differential impacts on patients’ QoL. Our hospital-based cross-sectional study assessed the QoL among 270 cancer patients at an Oncology center, comparing various types of cancers. Most patients were 41-50 years old (N = 89, 32.9%), consistent with Alam et al.’s findings [8]. Most of our participants (N = 173, 64.07%) completed higher secondary education, reiterating that educated people are more concerned about their health and seek early diagnosis and treatment for their medical problems [8].
In the EORTC QLQ-C30, higher scores on the Global Health Status/QoL scale correspond to better QoL. This is similar to the interpretation of our study, where higher scores correspond to better QoL [5]. Our study found that almost all patients (N = 267, 98.8%) had below-average QoL scores, heavily influenced by their symptoms. Patients reported very low general well-being (N = 228, 84.4%), had low self-esteem (N = 141, 52.2%), faced memory recall difficulties (N = 115, 42.6%), and relied heavily on medication for symptom relief (N = 180, 66.7%). These results align with Nayak et al.’s study conducted in India [9]. The findings of our study were also consistent with Gandhi et al., who conducted a cohort study involving 100 patients with advanced incurable head and neck cancer [10]. The study revealed that the patients experienced various symptoms, such as pain, insomnia, loss of appetite, and fatigue, which significantly impacted their normal functioning. Emotional functioning was affected in about 52.2% (N = 141) of the patients, while almost 80% (N = 216) of the population experienced a significant impact on their physical functioning [10].
Pain affected 52.6% (N = 141) of participants’ physical well-being, fatigue impacted 62.9% (N = 170), sleep problems were reported by 67.1% (N = 181), and appetite issues were almost universal. Notably, 59.8% (N = 159) felt they performed moderately well physically, and 52.6% (N = 142) were moderately confident in managing their financial needs. Pain, sleep problems, and fatigue were the most common issues affecting daily activities. Most participants had moderate problems with urination (N = 154, 57.1%) and bowel movements (N = 142, 52.6%). Despite numerous advancements in cancer treatment, the prevalence of physical and emotional symptoms remains high and can significantly impact the QoL of cancer patients [11]. Lin et al. assessed the pattern of symptoms in patients with advanced head and neck cancer in Taiwan and found that the most common symptom experienced was weight loss, followed by pain, cough, dysphagia, feeding difficulties, and communication difficulties [12]. Analysis done by Siemens et al. showed that one-fifth of the newly diagnosed advanced cancer patients experienced moderate or severe anxiety and depression symptoms and a very low QoL [13]. In our study, we observed that a significant proportion of patients experienced low levels of psychological well-being, which was similar to the study conducted by Marzo et al. [14].
In the current study, financial constraints are reported as the major issue among patients as well as family caregivers, which is the most common barrier to symptom management and has a bigger impact on QoL. Similar findings were reported in the studies by Alawadi and Ohaeri, Hopwood et al., Härtl et al., and Singh et al. [15-18]. Anxiety/depression and other symptoms were found to affect all dimensions of QoL, as reported by Bužgová et al. [19]. Cancer patients (N = 228, 84.4%) rated their overall QoL as moderate during the previous week and moderately poor physical condition during that week. Kannan et al. found that 80% of their study population had average or below-average QoL, similar to our findings [20]. Breast cancer patients have been observed to have low QoL scores in this study. Similarly, Knobf et al. found that breast cancer patients experienced low QoL scores due to changes in their body image [21]. Enien et al. conducted a study on Egyptian women with breast cancer and reported lower overall QoL in breast cancer survivors [22]. Our study identified cancer type as a significant factor affecting QoL, reporting moderate overall QoL. These results are in agreement with the study conducted by Deb Barma et al., who reported moderate QoL in head and neck cancer patients with significant functional impairments [23]. Similarly, Kumar et al. also observed moderate QoL, with cancer type being a major factor affecting QoL, whereas age, gender, and socioeconomic status have less influence on QoL. Psychological well-being and medication dependency are consistent across both studies [24]. Bhattacharjee and Ghosh emphasized spirituality and education as key predictors, with rural patients experiencing better QoL but facing severe social QoL challenges [25].
Limitations and future perspective
Limitations of our study include a small sample size and focus on just one region, plus relying on people’s own reports, which can be biased. The study only looks at a single point in time, missing long-term trends and other influencing factors. Future studies should involve a larger and more varied group of people, use various types of data, and monitor changes over time. Taking into account additional factors and cultural differences will provide a better understanding of how cancer impacts QoL.
Conclusions
This study highlights that cancer patients suffer from various symptoms affecting their QoL. Managing cancer pain is crucial, and health professionals need to be sympathetic toward these patients and help them overcome the physical, psychological, and financial constraints they experience. Healthcare professionals must develop effective measures for symptom management and empower patients with strategies for better control over their illness and treatment, improving their QoL.
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Krishna Vishwa Vidyapeeth (Deemed to be University) issued approval 202/2022-2023 dated: 17.1.2023. The study was carried out according to the Modified Helsinki Declaration (2000).
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.
Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.
Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Author Contributions
Concept and design: Girish Suragimath, Rajani Patil, Siddhartha Varma, Sameer A. Zope, Ashwinirani SR
Drafting of the manuscript: Girish Suragimath, Rajani Patil, Siddhartha Varma, Sameer A. Zope, Ashwinirani SR
Critical review of the manuscript for important intellectual content: Girish Suragimath, Siddhartha Varma, Sameer A. Zope, Ashwinirani SR
Acquisition, analysis, or interpretation of data: Rajani Patil
References
- 1.Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Indian J Med Res. 2022;156:598–607. doi: 10.4103/ijmr.ijmr_1821_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Psychosocial responses in breast cancer survivors. Knobf MT. Semin Oncol Nurs. 2007;23:71–83. doi: 10.1016/j.soncn.2006.11.009. [DOI] [PubMed] [Google Scholar]
- 3.Teoli D, Bhardwaj A. Treasure Island, FL: StatPearls Publishing; 2023. Quality of Life. [PubMed] [Google Scholar]
- 4.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 5.European Organisation for Research and Treatment of Cancer - Quality of Life. [ Jul; 2024 ]. 2018. https://www.eortc.org/app/uploads/sites/2/2018/08/Specimen-QLQ-C30-English.pdf https://www.eortc.org/app/uploads/sites/2/2018/08/Specimen-QLQ-C30-English.pdf
- 6.World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. World Medical Association. JAMA. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053. [DOI] [PubMed] [Google Scholar]
- 7.The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Aaronson NK, Ahmedzai S, Bergman B, et al. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365. [DOI] [PubMed] [Google Scholar]
- 8.Quality of life (QoL) of cancer patients and its association with nutritional and performance status: a pilot study. Alam MM, Rahman T, Afroz Z, Chakraborty PA, Wahab A, Zaman S, Hawlader MD. Heliyon. 2020;6:0. doi: 10.1016/j.heliyon.2020.e05250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Quality of life among cancer patients. Nayak MG, George A, Vidyasagar MS, et al. Indian J Palliat Care. 2017;23:445–450. doi: 10.4103/IJPC.IJPC_82_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Symptom burden and quality of life in advanced head and neck cancer patients: AIIMS study of 100 patients. Gandhi AK, Roy S, Thakar A, Sharma A, Mohanti BK. Indian J Palliat Care. 2014;20:189–193. doi: 10.4103/0973-1075.138389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Prevalence of symptoms and quality of life of cancer patients. Salvetti MG, Machado CS, Donato SC, Silva AM. Rev Bras Enferm. 2020;73:0. doi: 10.1590/0034-7167-2018-0287. [DOI] [PubMed] [Google Scholar]
- 12.Symptom patterns of patients with head and neck cancer in a palliative care unit. Lin YL, Lin IC, Liou JC. J Palliat Med. 2011;14:556–559. doi: 10.1089/jpm.2010.0461. [DOI] [PubMed] [Google Scholar]
- 13.Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: data from a multicenter cohort study. Siemens W, Schönsteiner SS, Orellana-Rios CL, et al. Support Care Cancer. 2020;28:5547–5555. doi: 10.1007/s00520-020-05388-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Study on the quality of life among cancer survivors attending a tertiary care cancer center in Malaysia. Marzo RR, Bhattacharya S, Aye SS, et al. J Public Health Res. 2022;10:0. doi: 10.4081/jphr.2021.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Health-related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire. Alawadi SA, Ohaeri JU. BMC Cancer. 2009;9:222. doi: 10.1186/1471-2407-9-222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial) Hopwood P, Haviland J, Mills J, Sumo G, M Bliss J. Breast. 2007;16:241–251. doi: 10.1016/j.breast.2006.11.003. [DOI] [PubMed] [Google Scholar]
- 17.Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Härtl K, Janni W, Kästner R, Sommer H, Strobl B, Rack B, Stauber M. Ann Oncol. 2003;14:1064–1071. doi: 10.1093/annonc/mdg289. [DOI] [PubMed] [Google Scholar]
- 18.Quality of life in cancer patients undergoing chemotherapy in a tertiary care center in malwa region of Punjab. Singh H, Kaur K, Banipal RP, Singh S, Bala R. Indian J Palliat Care. 2014;20:116–122. doi: 10.4103/0973-1075.132627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Assessing anxiety and depression with respect to the quality of life in cancer inpatients receiving palliative care. Bužgová R, Jarošová D, Hajnová E. Eur J Oncol Nurs. 2015;19:667–672. doi: 10.1016/j.ejon.2015.04.006. [DOI] [PubMed] [Google Scholar]
- 20.Assessment of quality of life of cancer patients in a tertiary care hospital of South India. Kannan G, Rani V, Ananthanarayanan RM, Palani T, Nigam N, Janardhan V, Reddy UM. J Cancer Res Ther. 2011;7:275–279. doi: 10.4103/0973-1482.87013. [DOI] [PubMed] [Google Scholar]
- 21.The effect of a community-based exercise intervention on symptoms and quality of life. Knobf MT, Thompson AS, Fennie K, Erdos D. Cancer Nurs. 2014;37:0–50. doi: 10.1097/NCC.0b013e318288d40e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Health-related quality of life: impact of surgery and treatment modality in breast cancer. Enien MA, Ibrahim N, Makar W, Darwish D, Gaber M. J Cancer Res Ther. 2018;14:957–963. doi: 10.4103/0973-1482.183214. [DOI] [PubMed] [Google Scholar]
- 23.Quality of life among head and neck cancer treated patients in South India: a cross-sectional study. Deb Barma M, Indiran MA, Kumar R P, Balasubramaniam A, Kumar MP. J Oral Biol Craniofac Res. 2021;11:215–218. doi: 10.1016/j.jobcr.2021.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Factors affecting quality of life of cancer patients in North India. Kumar K, Mittal A, Kamboj D, Goel GS, Mittal A, Garg SK. Asian Pac J Cancer Prev. 2023;24:641–648. doi: 10.31557/APJCP.2023.24.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Predictors of quality of life of cancer patients: a psycho-oncological study conducted at Tripura, North-East India [IN PRESS] Bhattacharjee A, Ghosh T. Indian J Cancer. 2023 doi: 10.4103/ijc.ijc_389_21. [DOI] [PubMed] [Google Scholar]